• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

FYB:GR

6.787 EUR 0.030 0.44%

As of 08:15:09 ET on 08/20/2014.

Snapshot for Formycon AG (FYB)

Open: 6.757 Day's Range: 6.757 - 6.851 Volume: 7,750
Previous Close: 6.757 52wk Range: 6.200 - 8.770 1-Yr Rtn: -5.83%

Stock Chart for FYB

No chart data available.
  • FYB:GR 6.787
  • 1D
  • 1M
  • 1Y
6.757
Interactive FYB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FYB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.8969
Est. EPS (EUR) (12/2014) -0.1950
Est. PEG Ratio -
Market Cap (M EUR) 62.52
Shares Outstanding (M) 9.21
30 Day Average Volume 5,958
Price/Book (mrq) 4.7811
Price/Sale (ttm) 212.0837
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FYB

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for FYB

Formycon AG is a biopharmaceutical company with more than twelve years experience in product development. The company's activities focus on developing and marketing "biosimilars" - biopharmaceuticals which are similar to existing drugs for which patent protection is expiring - as well as the provision of contract services to other biotechnology and pharmaceutical companies.

Carsten BrockmeyerChairman-Mgmt Board/CEONicolas CombeCFO/Member-Mgmt Board
More Company Profile & Key Executives for FYB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil